Hypera (OTCMKTS:HYPMY) Stock Price Crosses Above Fifty Day Moving Average of $8.53
Hypera (OTCMKTS:HYPMY) Stock Price Crosses Above Fifty Day Moving Average of $8.53
Hypera S.A. (OTCMKTS:HYPMY – Get Rating)'s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $8.53 and traded as high as $8.69. Hypera shares last traded at $8.57, with a volume of 1,268 shares trading hands.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group raised Hypera from a "neutral" rating to a "buy" rating in a report on Monday, October 17th.
Get Hypera alerts:Hypera Stock Up 6.0 %
The firm has a fifty day moving average of $8.56 and a 200 day moving average of $8.01.
Hypera Company Profile
(Get Rating)Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Read More
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
- Can Comcast Monetize Existing Users for Streaming Success?
- Chevron Gushes More Profits; Is it Time for Investors to Buy?
- Why is Amazon Stock Falling? Is the Sell-Off Overdone?
- Will Ryanair Stock Gains, Strong Estimates Help it Fly?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
Hypera S.A. (OTCMKTS:HYPMY – Get Rating)'s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $8.53 and traded as high as $8.69. Hypera shares last traded at $8.57, with a volume of 1,268 shares trading hands.
在週三的交易中,Hypera S.A.(場外交易代碼:HYPMY-GET Rating)的股價超過了50日移動均線。該股的50日移動均線為8.53美元,最高交易價格為8.69美元。Hypera的股票最新報8.57美元,成交量為1,268股。
Analyst Upgrades and Downgrades
分析師升級和下調評級
Separately, The Goldman Sachs Group raised Hypera from a "neutral" rating to a "buy" rating in a report on Monday, October 17th.
另外,高盛在10月17日星期一的一份報告中將Hypera的評級從中性上調至買入。
Hypera Stock Up 6.0 %
Hypera股價上漲6.0%
The firm has a fifty day moving average of $8.56 and a 200 day moving average of $8.01.
該公司的50日移動均線切入位在8.56美元,200日移動均線切入位在8.01美元。
Hypera Company Profile
Hypera公司簡介
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA在巴西作為一家制藥公司運營。它提供的處方藥有Adacne、Addera、Apri、AmpliumG、請、賽萊他明、Celstone、Celstone Soluspana、Cizax、DECPRAX、衍生CMicro、Micro Drift、Dermol Fusid、Digedrat、雙丙胺、雙丙沙星、雙丙鬆、雙丙鬆、Emprol XR、Flow、Garasone、Halobx、Lipanon、Moon、Lydian、Macrodantin、MaxSulid、MilGamma、Mioflex-A、Nesina、Novotram、oximax、peridid、Perida混懸劑、Predsim、Pressaliv、Quadriderm、Rizi、Rizi、Softalm、acrotz、tinodin、umma和velunid品牌。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
- Can Comcast Monetize Existing Users for Streaming Success?
- Chevron Gushes More Profits; Is it Time for Investors to Buy?
- Why is Amazon Stock Falling? Is the Sell-Off Overdone?
- Will Ryanair Stock Gains, Strong Estimates Help it Fly?
- 免費獲取StockNews.com關於Hypera的研究報告(HYPMY)
- 麥當勞股價下跌,但它會創下歷史新高嗎?
- 康卡斯特能否通過流媒體的成功將現有用户貨幣化?
- 雪佛龍獲得更多利潤;投資者是時候買入了嗎?
- 為什麼亞馬遜的股票會下跌?拋售是否過頭了?
- 瑞安航空股價上漲,強勁的預期是否會幫助它飛起來?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Hypera Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Hypera和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧